As filed with the Securities and Exchange Commission on January 14, 2000
                                                      Registration No. 333-_____

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   -----------

                                    Form S-8
                             REGISTRATION STATEMENT
                                      Under
                           THE SECURITIES ACT OF 1933

                                   -----------

                                MEDICALOGIC, INC.
             (Exact name of registrant as specified in its charter)

                                   -----------

               OREGON                                   93-0890696
    (State or other jurisdiction of                  (I.R.S. Employer
     incorporation or organization)               Identification Number)


                                   -----------

                           20500 NW EVERGREEN PARKWAY
                             HILLSBORO, OREGON 97124
                                 (503) 531-7000
(Address, including zip code, and telephone number, including area code, of
Registrant's principal executive offices)

                                   -----------

                                MEDICALOGIC, INC
                        1999 EMPLOYEE STOCK PURCHASE PLAN
                              (Full title of plan)

                                   -----------

                                 MARK K. LEAVITT
                             CHIEF EXECUTIVE OFFICER
                           20500 NW EVERGREEN PARKWAY
                             HILLSBORO, OREGON 97124
                                 (503) 531-7000
           (Name, address, including zip code, and telephone number,
                   including area code, of agent for service)

                                   -----------

                                   Copies to:

                                 TODD A. BAUMAN
                                 Stoel Rives LLP
                         900 SW Fifth Avenue, Suite 2600
                           Portland, Oregon 97204-1268
                                 (503) 224-3380

<PAGE>
<TABLE>
<CAPTION>
                         CALCULATION OF REGISTRATION FEE
--------------------------------------------------------------------------------------
                                               Proposed       Proposed
                                               Maximum        Maximum        Amount
                         Amount                Offering       Aggregate      of Regis-
Title of Securities      to Be                 Price Per      Offering       tration
to Be Registered         Registered            Share (1)      Price (1)      Fee
-------------------      ----------            ---------      ---------      ---------
<S>                      <C>                   <C>            <C>            <C>
Common Stock             1,000,000 shares      $25.75         $25,750,000    $6,798
--------------------------------------------------------------------------------------
(1)  The proposed maximum offering price per share and proposed maximum
     aggregate offering price were estimated solely for the purpose of
     calculating the registration fee pursuant to Rule 457(h) and Rule 457(c)
     under the Securities Act of 1933. The calculation of the registration fee
     is based on the average of the high and low prices of the common stock on
     the Nasdaq National Market for January 7, 2000.
</TABLE>

<PAGE>
                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents By Reference.

     The following documents filed by MedciaLogic, Inc. (the "Registrant") with
the Securities and Exchange Commission are incorporated herein by reference:

          (a) The Registrant's latest annual report filed pursuant to Section
     13(a) or 15(d) of the Securities Exchange Act of 1934 or the latest
     prospectus filed pursuant to rule 424(b) under the Securities Act of 1933
     that contains audited financial statements for the Registrant's latest
     fiscal year for which such statements have been filed.

          (b) All other reports filed pursuant to Section 13(a) or 15(d) of the
     Securities Exchange Act of 1934 since the end of the fiscal year covered by
     the annual report or prospectus referred to in (a) above.

          (c) The description of the authorized capital stock of the Registrant
     contained in the Registrant's registration statement filed under Section 12
     of the Securities Exchange Act of 1934, as amended, including any amendment
     or report filed for the purpose of updating the description.

     All reports and other documents subsequently filed by the Registrant
pursuant to Sections 13(a) and (c), 14 and 15(d) of the Securities Exchange Act
of 1934, as amended, prior to the filing of a post-effective amendment which
indicates that all securities offered hereby have been sold or which deregisters
all securities remaining unsold, shall be deemed to be incorporated by reference
herein and to be a part hereof from the date of the filing of such reports and
documents.

Item 4. Description of Securities.

     Not Applicable.

Item 5. Interests of Named Experts and Counsel.

     Stoel Rives LLP, Portland, Oregon, holds a warrant to purchase 10,000
shares of Registrant's common stock at an exercise price of $6.50 a share.
Partners and employees of Stoel Rives LLP beneficially own an aggregate of
47,000 shares of the Registrant's common stock.

                                      II-1
<PAGE>
Item 6. Indemnification of Directors and Officers.

     Article IV of the Registrant's Restated Articles of Incorporation requires
indemnification of current or former directors of the Registrant to the fullest
extent not prohibited by the Oregon Business Corporation Act. The Oregon
Business Corporation Act permits or requires indemnification of directors and
officers in certain circumstances. The effects of the indemnification provisions
are as follows:

          (a) The indemnification provisions grant a right of indemnification in
     respect of any proceeding (other than an action by or in the right of the
     Registrant) if the person concerned acted in good faith and in a manner the
     person reasonably believed to be in or not opposed to the best interests of
     the Registrant, was not adjudged liable on the basis of receipt of an
     improper personal benefit and, with respect to any criminal action or
     proceeding, had no reasonable cause to believe the conduct was unlawful.
     The termination of a proceeding by judgment, order, settlement, conviction
     or plea of nolo contendere, or its equivalent, is not, of itself,
     determinative that the person did not meet the required standards of
     conduct.

          (b) The indemnifications provisions grant a right of indemnification
     in respect of any proceeding by or in the right of the Registrant against
     expenses (including attorneys' fees), judgments, fines and amounts paid in
     settlement actually and reasonably incurred, provided the person concerned
     acted in good faith and in a manner the person reasonably believed to be in
     or not opposed to the best interests of the Registrant, except that no
     right of indemnification will be granted if the person is adjudged to be
     liable to the Registrant.

          (c) Every person who has been wholly successful, on the merits or
     otherwise, in the defense of any proceeding to which the person was a party
     because of the person's status as a director or officer is entitled to
     indemnification as a matter of right.

          (d) Because the limits of permissible indemnification under Oregon law
     are not clearly defined, the indemnification provisions may provide
     indemnifications broader than that described in (a) and (b).

          (e) The Registrant may advance to a director or officer the expenses
     incurred in defending any proceeding in advance of its final disposition if
     the director or officer affirms in writing in good faith that he or she has
     met the standard of conduct to be entitled to indemnification as described
     in (a) or (b) above and undertakes to repay any amount advanced if it is
     determined that the person did not meet the required standard of conduct.

     The Registrant has obtained insurance for the protection of its directors
and officers against any liability asserted against them in their official
capacities. The rights of

                                      II-2
<PAGE>
indemnification described above are not exclusive of any other rights of
indemnification to which the persons indemnified may be entitled under any
bylaw, agreement, vote of shareholders or directors or otherwise.


Item 7. Exemption From Registration Claimed.

     Not Applicable.

Item 8. Exhibits.

     4.1    1999 Restated Articles of Incorporation of the Registrant.

     4.2    Restated Bylaws of the Registrant (incorporated by reference to
            Exhibit 3.2 to the Registrant's Registration Statement on Form S-1,
            as amended (Registration No. 333-87285)).

     5.1    Opinion of Stoel Rives LLP.

     23.1   Consent of KPMG LLP.

     23.2   Consent of KPMG LLP.

     23.3   Consent of Stoel Rives LLP (included in Exhibit 5.1).

     24.1   Power of Attorney (included on signature page)

Item 9.  Undertakings.

     (a)  The Registrant hereby undertakes:

          (1) To file, during any period in which offers or sales are being
     made, a post-effective amendment to this registration statement:

               (i) To include any prospectus required by Section 10(a)(3) of the
          Securities Act of 1933;

                                     II-3
<PAGE>
               (ii) To reflect in the prospectus any facts or events arising
          after the effective date of the registration statement (or the most
          recent post-effective amendment thereof) which, individually or in the
          aggregate, represent a fundamental change in the information set forth
          in the registration statement. Notwithstanding the foregoing, any
          increase or decrease in volume of securities offered (if the total
          dollar value of securities offered would not exceed that which was
          registered) and any deviation from the low or high end of the
          estimated maximum offering range may be reflected in the form of
          prospectus filed with the Commission pursuant to Rule 424(b) if, in
          the aggregate, the changes in volume and price represent no more than
          a 20% change in the maximum aggregate offering price set forth in the
          "Calculation of Registration Fee" table in the effective registration
          statement.

               (iii) To include any material information with respect to the
          plan of distribution not previously disclosed in the registration
          statement or any material change to such information in the
          registration statement;

     PROVIDED, HOWEVER, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if
     the information required to be included in a post-effective amendment by
     those paragraphs is contained in periodic reports filed by the registrant
     pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of
     1934 that are incorporated by reference in the registration statement.

          (2) That, for the purpose of determining any liability under the
     Securities Act of 1933, each such post-effective amendment shall be deemed
     to be a new registration statement relating to the securities offered
     therein, and the offering of such securities at that time shall be deemed
     to be the initial bona fide offering thereof.

          (3) To remove from registration by means of a post-effective amendment
     any of the securities being registered which remain unsold at the
     termination of the offering.

     (b)  The Registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act of 1933, each filing of the registrant's
annual report pursuant to Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.

                                      II-4
<PAGE>
     (c) Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions, or otherwise, the
Registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act
and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses
incurred or paid by a director, officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.

                                      II-5
<PAGE>
                                   SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Hillsboro, State of Oregon on January 14, 2000.

                                       MEDICALOGIC, INC.


                                       By MARK K. LEAVITT
                                          -------------------------------------
                                          Mark K. Leavitt, M.D.
                                          Chief Executive Officer

     Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement on Form S-8 has been signed below by the following
persons in the capacities indicated on January 14, 2000.

                                POWER OF ATTORNEY
                                -----------------


     KNOW ALL MEN BY THESE PRESENTS, that the undersigned, an officer and/or
director of MedicaLogic, Inc., does hereby constitute and appoint Mark K.
Leavitt and David C. Moffenbeier his true and lawful attorney and agent to do
any and all acts and things and to execute in his name (whether on behalf of
MedicaLogic, Inc., or as an officer or director of said Registrant, or
otherwise) any and all instruments which said attorney and agent may deem
necessary or advisable in order to enable MedicaLogic, Inc. to comply with the
Securities Act of 1933, as amended, and any requirements of the Securities and
Exchange Commission in respect thereof, in connection with the registration
under the Securities Act of 1933, as amended, of 1,000,000 shares of Common
Stock of MedicaLogic, Inc., issuable pursuant to the 1999 Employee Stock
Purchase Plan, including specifically, but without limitation thereto, power and
authority to sign his name (whether on behalf of MedicaLogic, Inc., or as an
officer or director of said Registrant, or otherwise) to a Registration
Statement on Form S-8 and any amendment thereto (including any post-effective
amendment) or application for amendment thereto in respect to such Common Stock
or any exhibits filed therewith; and to file the same with the Securities and
Exchange Commission; and the undersigned does hereby ratify and confirm all that
said attorney and agent shall do or cause to be done by virtue hereof.

         Signature                          Title
         ---------                          -----

         MARK K. LEAVITT                    Chairman of the Board
         --------------------               and Chief Executive Officer
         Mark K. Leavitt, M.D.              Principal Executive Officer

                                      II-6
<PAGE>
         FRANK J. SPINA                     Senior Vice President
         --------------------               and Chief Financial Officer
         Frank J. Spina                     Principal Financial and
                                            Accounting Officer

         BRUCE M. FRIED                     Director
         --------------------
         Bruce M. Fried


         RONALD H. KASE                     Director
         --------------------
         Ronald H. Kase


         DAVID C. MOFFENBEIER               Director
         --------------------
         David C. Moffenbeier


         NEAL MOSZKOWSKI                    Director
         --------------------
         Neal Moszkowski


         MARK A. STEVENS                    Director
         --------------------
         Mark A. Stevens


         RONALD R. TAYLOR                   Director
         --------------------
         Ronald R. Taylor


                                            Director
         --------------------
         David W. Wroe

                                      11-7
<PAGE>
                                  EXHIBIT INDEX

Exhibit
Number            Document Description
--------          --------------------

4.1               1999 Restated Articles of Incorporation of the Registrant.

4.2               Restated Bylaws of the Registrant (incorporated by reference
                  to Exhibit 3.2 to the Registrant's Registration Statement on
                  Form S-1, as amended (Registration No. 333-87285)).

5.1               Opinion of Stoel Rives LLP.

23.1              Consent of KPMG LLP.

23.2              Consent of KPMG LLP.

23.3              Consent of Stoel Rives LLP (included in Exhibit 5.1).

24.1              Power of Attorney (included on signature page)
[{"type": "S-8", "sequence": "1", "description": "FORM S-8", "secsgml_size_bytes": 18667}]
{"company-data": {"conformed-name": "MEDICALOGIC INC", "cik": "0000923899", "assigned-sic": "7374", "irs-number": "930890696", "state-of-incorporation": "OR", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-94751", "film-number": "508072"}, "business-address": {"street1": "20500 NW EVERGREEN PARKWAY", "street2": "STE 400", "city": "HILLSBORO", "state": "OR", "zip": "97124", "phone": "5036456442"}, "mail-address": {"street1": "20500 NW EVERGREEN PARKWAY", "city": "HILLSBORO", "state": "OR", "zip": "97124"}}
As filed with the Securities and Exchange Commission on January 14, 2000
                                                      Registration No. 333-_____

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   -----------

                                    Form S-8
                             REGISTRATION STATEMENT
                                      Under
                           THE SECURITIES ACT OF 1933

                                   -----------

                                MEDICALOGIC, INC.
             (Exact name of registrant as specified in its charter)

                                   -----------

               OREGON                                   93-0890696
    (State or other jurisdiction of                  (I.R.S. Employer
     incorporation or organization)               Identification Number)

                                   -----------

                           20500 NW EVERGREEN PARKWAY
                             HILLSBORO, OREGON 97124
                                 (503) 531-7000
(Address, including zip code, and telephone number, including area code, of
Registrant's principal executive offices)

                                   -----------

                                MEDICALOGIC, INC
                        1999 EMPLOYEE STOCK PURCHASE PLAN
                              (Full title of plan)

                                   -----------

                                 MARK K. LEAVITT
                             CHIEF EXECUTIVE OFFICER
                           20500 NW EVERGREEN PARKWAY
                             HILLSBORO, OREGON 97124
                                 (503) 531-7000
           (Name, address, including zip code, and telephone number,
                   including area code, of agent for service)

                                   -----------

                                   Copies to:

                                 TODD A. BAUMAN
                                 Stoel Rives LLP
                         900 SW Fifth Avenue, Suite 2600
                           Portland, Oregon 97204-1268
                                 (503) 224-3380
CALCULATION OF REGISTRATION FEE
--------------------------------------------------------------------------------------
                                               Proposed       Proposed
                                               Maximum        Maximum        Amount
                         Amount                Offering       Aggregate      of Regis-
Title of Securities      to Be                 Price Per      Offering       tration
to Be Registered         Registered            Share (1)      Price (1)      Fee
-------------------      ----------            ---------      ---------      ---------
Common Stock             1,000,000 shares      $25.75         $25,750,000    $6,798
--------------------------------------------------------------------------------------
(1)  The proposed maximum offering price per share and proposed maximum
     aggregate offering price were estimated solely for the purpose of
     calculating the registration fee pursuant to Rule 457(h) and Rule 457(c)
     under the Securities Act of 1933. The calculation of the registration fee
     is based on the average of the high and low prices of the common stock on
     the Nasdaq National Market for January 7, 2000.
PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents By Reference.

     The following documents filed by MedciaLogic, Inc. (the "Registrant") with
the Securities and Exchange Commission are incorporated herein by reference:

          (a) The Registrant's latest annual report filed pursuant to Section
     13(a) or 15(d) of the Securities Exchange Act of 1934 or the latest
     prospectus filed pursuant to rule 424(b) under the Securities Act of 1933
     that contains audited financial statements for the Registrant's latest
     fiscal year for which such statements have been filed.

          (b) All other reports filed pursuant to Section 13(a) or 15(d) of the
     Securities Exchange Act of 1934 since the end of the fiscal year covered by
     the annual report or prospectus referred to in (a) above.

          (c) The description of the authorized capital stock of the Registrant
     contained in the Registrant's registration statement filed under Section 12
     of the Securities Exchange Act of 1934, as amended, including any amendment
     or report filed for the purpose of updating the description.

     All reports and other documents subsequently filed by the Registrant
pursuant to Sections 13(a) and (c), 14 and 15(d) of the Securities Exchange Act
of 1934, as amended, prior to the filing of a post-effective amendment which
indicates that all securities offered hereby have been sold or which deregisters
all securities remaining unsold, shall be deemed to be incorporated by reference
herein and to be a part hereof from the date of the filing of such reports and
documents.

Item 4. Description of Securities.

     Not Applicable.

Item 5. Interests of Named Experts and Counsel.

     Stoel Rives LLP, Portland, Oregon, holds a warrant to purchase 10,000
shares of Registrant's common stock at an exercise price of $6.50 a share.
Partners and employees of Stoel Rives LLP beneficially own an aggregate of
47,000 shares of the Registrant's common stock.

                                      II-1
Item 6. Indemnification of Directors and Officers.

     Article IV of the Registrant's Restated Articles of Incorporation requires
indemnification of current or former directors of the Registrant to the fullest
extent not prohibited by the Oregon Business Corporation Act. The Oregon
Business Corporation Act permits or requires indemnification of directors and
officers in certain circumstances. The effects of the indemnification provisions
are as follows:

          (a) The indemnification provisions grant a right of indemnification in
     respect of any proceeding (other than an action by or in the right of the
     Registrant) if the person concerned acted in good faith and in a manner the
     person reasonably believed to be in or not opposed to the best interests of
     the Registrant, was not adjudged liable on the basis of receipt of an
     improper personal benefit and, with respect to any criminal action or
     proceeding, had no reasonable cause to believe the conduct was unlawful.
     The termination of a proceeding by judgment, order, settlement, conviction
     or plea of nolo contendere, or its equivalent, is not, of itself,
     determinative that the person did not meet the required standards of
     conduct.

          (b) The indemnifications provisions grant a right of indemnification
     in respect of any proceeding by or in the right of the Registrant against
     expenses (including attorneys' fees), judgments, fines and amounts paid in
     settlement actually and reasonably incurred, provided the person concerned
     acted in good faith and in a manner the person reasonably believed to be in
     or not opposed to the best interests of the Registrant, except that no
     right of indemnification will be granted if the person is adjudged to be
     liable to the Registrant.

          (c) Every person who has been wholly successful, on the merits or
     otherwise, in the defense of any proceeding to which the person was a party
     because of the person's status as a director or officer is entitled to
     indemnification as a matter of right.

          (d) Because the limits of permissible indemnification under Oregon law
     are not clearly defined, the indemnification provisions may provide
     indemnifications broader than that described in (a) and (b).

          (e) The Registrant may advance to a director or officer the expenses
     incurred in defending any proceeding in advance of its final disposition if
     the director or officer affirms in writing in good faith that he or she has
     met the standard of conduct to be entitled to indemnification as described
     in (a) or (b) above and undertakes to repay any amount advanced if it is
     determined that the person did not meet the required standard of conduct.

     The Registrant has obtained insurance for the protection of its directors
and officers against any liability asserted against them in their official
capacities. The rights of

                                      II-2
indemnification described above are not exclusive of any other rights of
indemnification to which the persons indemnified may be entitled under any
bylaw, agreement, vote of shareholders or directors or otherwise.

Item 7. Exemption From Registration Claimed.

     Not Applicable.

Item 8. Exhibits.

     4.1    1999 Restated Articles of Incorporation of the Registrant.

     4.2    Restated Bylaws of the Registrant (incorporated by reference to
            Exhibit 3.2 to the Registrant's Registration Statement on Form S-1,
            as amended (Registration No. 333-87285)).

     5.1    Opinion of Stoel Rives LLP.

     23.1   Consent of KPMG LLP.

     23.2   Consent of KPMG LLP.

     23.3   Consent of Stoel Rives LLP (included in Exhibit 5.1).

     24.1   Power of Attorney (included on signature page)

Item 9.  Undertakings.

     (a)  The Registrant hereby undertakes:

          (1) To file, during any period in which offers or sales are being
     made, a post-effective amendment to this registration statement:

               (i) To include any prospectus required by Section 10(a)(3) of the
          Securities Act of 1933;

                                     II-3
(ii) To reflect in the prospectus any facts or events arising
          after the effective date of the registration statement (or the most
          recent post-effective amendment thereof) which, individually or in the
          aggregate, represent a fundamental change in the information set forth
          in the registration statement. Notwithstanding the foregoing, any
          increase or decrease in volume of securities offered (if the total
          dollar value of securities offered would not exceed that which was
          registered) and any deviation from the low or high end of the
          estimated maximum offering range may be reflected in the form of
          prospectus filed with the Commission pursuant to Rule 424(b) if, in
          the aggregate, the changes in volume and price represent no more than
          a 20% change in the maximum aggregate offering price set forth in the
          "Calculation of Registration Fee" table in the effective registration
          statement.

               (iii) To include any material information with respect to the
          plan of distribution not previously disclosed in the registration
          statement or any material change to such information in the
          registration statement;

     PROVIDED, HOWEVER, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if
     the information required to be included in a post-effective amendment by
     those paragraphs is contained in periodic reports filed by the registrant
     pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of
     1934 that are incorporated by reference in the registration statement.

          (2) That, for the purpose of determining any liability under the
     Securities Act of 1933, each such post-effective amendment shall be deemed
     to be a new registration statement relating to the securities offered
     therein, and the offering of such securities at that time shall be deemed
     to be the initial bona fide offering thereof.

          (3) To remove from registration by means of a post-effective amendment
     any of the securities being registered which remain unsold at the
     termination of the offering.

     (b)  The Registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act of 1933, each filing of the registrant's
annual report pursuant to Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.

                                      II-4
(c) Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions, or otherwise, the
Registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act
and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses
incurred or paid by a director, officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.

                                      II-5
SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Hillsboro, State of Oregon on January 14, 2000.

                                       MEDICALOGIC, INC.

                                       By MARK K. LEAVITT
                                          -------------------------------------
                                          Mark K. Leavitt, M.D.
                                          Chief Executive Officer

     Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement on Form S-8 has been signed below by the following
persons in the capacities indicated on January 14, 2000.

                                POWER OF ATTORNEY
                                -----------------

     KNOW ALL MEN BY THESE PRESENTS, that the undersigned, an officer and/or
director of MedicaLogic, Inc., does hereby constitute and appoint Mark K.
Leavitt and David C. Moffenbeier his true and lawful attorney and agent to do
any and all acts and things and to execute in his name (whether on behalf of
MedicaLogic, Inc., or as an officer or director of said Registrant, or
otherwise) any and all instruments which said attorney and agent may deem
necessary or advisable in order to enable MedicaLogic, Inc. to comply with the
Securities Act of 1933, as amended, and any requirements of the Securities and
Exchange Commission in respect thereof, in connection with the registration
under the Securities Act of 1933, as amended, of 1,000,000 shares of Common
Stock of MedicaLogic, Inc., issuable pursuant to the 1999 Employee Stock
Purchase Plan, including specifically, but without limitation thereto, power and
authority to sign his name (whether on behalf of MedicaLogic, Inc., or as an
officer or director of said Registrant, or otherwise) to a Registration
Statement on Form S-8 and any amendment thereto (including any post-effective
amendment) or application for amendment thereto in respect to such Common Stock
or any exhibits filed therewith; and to file the same with the Securities and
Exchange Commission; and the undersigned does hereby ratify and confirm all that
said attorney and agent shall do or cause to be done by virtue hereof.

         Signature                          Title
         ---------                          -----

         MARK K. LEAVITT                    Chairman of the Board
         --------------------               and Chief Executive Officer
         Mark K. Leavitt, M.D.              Principal Executive Officer

                                      II-6
FRANK J. SPINA                     Senior Vice President
         --------------------               and Chief Financial Officer
         Frank J. Spina                     Principal Financial and
                                            Accounting Officer

         BRUCE M. FRIED                     Director
         --------------------
         Bruce M. Fried

         RONALD H. KASE                     Director
         --------------------
         Ronald H. Kase

         DAVID C. MOFFENBEIER               Director
         --------------------
         David C. Moffenbeier

         NEAL MOSZKOWSKI                    Director
         --------------------
         Neal Moszkowski

         MARK A. STEVENS                    Director
         --------------------
         Mark A. Stevens

         RONALD R. TAYLOR                   Director
         --------------------
         Ronald R. Taylor

                                            Director
         --------------------
         David W. Wroe

                                      11-7
EXHIBIT INDEX

Exhibit
Number            Document Description
--------          --------------------

4.1               1999 Restated Articles of Incorporation of the Registrant.

4.2               Restated Bylaws of the Registrant (incorporated by reference
                  to Exhibit 3.2 to the Registrant's Registration Statement on
                  Form S-1, as amended (Registration No. 333-87285)).

5.1               Opinion of Stoel Rives LLP.

23.1              Consent of KPMG LLP.

23.2              Consent of KPMG LLP.

23.3              Consent of Stoel Rives LLP (included in Exhibit 5.1).

24.1              Power of Attorney (included on signature page)